REPH Recro Pharma Inc.

8.36
+0.13  (+2%)
Previous Close 8.23
Open 8.21
Price To Book -9.39
Market Cap 183842545
Shares 21,990,735
Volume 277,077
Short Ratio
Av. Daily Volume 530,954

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

First CRL announced May 24, 2018. Second CRL issued March 22, 2019.
Intravenous (IV) meloxicam
Acute pain following bunionectomy surgery

Latest News

  1. Recro Pharma Announces Six-Year Extension of License and Supply Agreement Between Teva and Recro Gainesville
  2. Recro Pharma Announces Presentation of New Meta-Analysis for IV Meloxicam at the 44th Annual Regional Anesthesiology and Acute Pain Medicine Meeting
  3. Recro Pharma eliminates 50 jobs following FDA setback
  4. The Daily Biotech Pulse: Recro Restructures, Biotechs Raise Proceeds In Droves, Silk Road, NGM Biopharma To Debut
  5. Recro Pharma Restructures Acute Care Segment While Continuing To Execute on Strong CDMO Segment Performance
  6. Recro Pharma Falls as FDA Denies Approval to Pain Candidate
  7. Why Recro Pharma's stock price plunged more than 34% today
  8. More Pain For Recro Pharma: FDA Rejects Meloxicam NDA For Second Time
  9. Recro Pharma's stock plunges to pace premarket decliners after 2nd CRL for pain treatment
  10. Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
  11. FDA rejects Malvern pharma firm's non-opioid pain killer for a second time
  12. Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
  13. Recro Pharma to Host Educational Symposium on Pain Management Options in Total Joint Replacements at the American Academy of Orthopaedic Surgeons 2019 Annual Meeting
  14. Options Traders Expect Huge Moves in Recro Pharma (REPH) Stock
  15. Recro Pharma Obtains $40.5 Million of Non-Dilutive Capital Through Expanded Credit Facility
  16. Recro Pharma Announces Publication of Phase III IV Meloxicam Clinical Safety and Opioid Use Data in the Journal Clinical Pharmacology in Drug Development
  17. Edited Transcript of REPH earnings conference call or presentation 19-Feb-19 1:00pm GMT
  18. Recro Pharma Announces New IV Meloxicam Data Publication in the Journal Regional Anesthesia & Pain Medicine
  19. Recro Pharma: 4Q Earnings Snapshot